IL-2 Variants and IL-15: A Deep Dive in Cancer Immunotherapy Targets

When:  Jul 19, 2021 from 16:30 to 18:30 (ET)

The Society for Immunotherapy of Cancer (SITC) is pleased to offer a highly anticipated series of eight, online seminars to address key questions in the field of cancer immunotherapy, both in-depth and in an easily accessible format. "IL-2 Variants and IL-15: A Deep Dive in Cancer Immunotherapy Targets" is the third seminar in the series.

Co-chairs:

  • Rafi Ahmed, PhD – Emory University
  • Michael B. Atkins, MD – Georgetown Lombardi Comprehensive Cancer Center
  • Warren J. Leonard, MD – Laboratory of Molecular Immunology, NHLBI

Faculty:

  • Michael B. Atkins, MD – Georgetown Lombardi Comprehensive Cancer Center
  • Warren J. Leonard, MD – Laboratory of Molecular Immunology, NHLBI
  • Jamie B. Spangler, PhD – Johns Hopkins University
  • Thomas A. Waldmann, MD – National Cancer Institute, National Institutes of Health

    Seminar agenda:

    • 4:30-4:35 pm ET: Welcome and Introductions
    • 4:35-5:50 pm ET: Faculty Presentations
    • 5:50-6:20 pm ET: Question and Answer Session
    • 6:20-6:30 pm ET: Closing Remarks

    This webinar is supported, in part, by independent medical education grant funding from Alkermes, Inc., Genentech, a member of the Roche Group, Incyte Corporation, and Merck & Co., Inc.
    More information